CLINICAL_TRIALS
trial_result
· 2013-01-24
Clinical Trial Update: Cilengitide in Treating Patients With Acute Myeloid Leukemia [Phase 2]
Summary
A Phase 2 trial of cilengitide for acute myeloid leukemia was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 2 | Status: TERMINATED